Variant report
Variant | rs56166222 |
---|---|
Chromosome Location | chr16:81101525-81101526 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:81097425..81099177-chr16:81100146..81103114,2 | MCF-7 | breast: | |
2 | chr16:81100809..81103284-chr16:81103870..81105731,2 | MCF-7 | breast: | |
3 | chr16:81100280..81102039-chr16:81103026..81105391,2 | K562 | blood: | |
4 | chr16:81096522..81104265-chr16:81107324..81112531,10 | MCF-7 | breast: | |
5 | chr16:81097663..81102945-chr16:81104726..81108274,4 | K562 | blood: | |
6 | chr16:81099686..81101750-chr16:81106267..81108308,2 | K562 | blood: | |
7 | chr16:81100539..81102214-chr16:81102627..81104526,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261838 | Chromatin interaction |
ENSG00000245059 | Chromatin interaction |
ENSG00000166455 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1035541 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs10459871 | 0.90[AFR][1000 genomes];0.94[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs10459872 | 0.90[AFR][1000 genomes];0.94[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs1048194 | 0.82[EUR][1000 genomes] |
rs1050364 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10514512 | 0.85[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10514513 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs10514514 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10514515 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11150338 | 0.83[ASN][1000 genomes] |
rs11537 | 0.89[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11863158 | 0.82[AMR][1000 genomes] |
rs12443549 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs12444137 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs12444747 | 0.82[EUR][1000 genomes] |
rs12444969 | 0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs12445303 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12448806 | 0.87[EUR][1000 genomes] |
rs12456 | 0.80[EUR][1000 genomes] |
rs12598621 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs1410 | 0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs1412 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1414 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1563072 | 0.89[EUR][1000 genomes] |
rs1563075 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1563077 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs16954572 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs16954582 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs1814543 | 0.86[EUR][1000 genomes] |
rs1965237 | 0.81[ASN][1000 genomes] |
rs2278022 | 0.89[AMR][1000 genomes];0.87[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2278024 | 0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2287995 | 0.94[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2316730 | 0.87[EUR][1000 genomes] |
rs2316731 | 0.92[EUR][1000 genomes] |
rs2317085 | 0.95[EUR][1000 genomes] |
rs2317086 | 0.94[EUR][1000 genomes] |
rs2317087 | 0.87[EUR][1000 genomes] |
rs2549891 | 0.83[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs28391685 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs28613188 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs28672349 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs35096487 | 0.89[AMR][1000 genomes] |
rs4306521 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4324141 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4324142 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4324143 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs4454990 | 0.95[EUR][1000 genomes] |
rs4889225 | 0.87[EUR][1000 genomes] |
rs4889227 | 0.84[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4889229 | 0.87[EUR][1000 genomes] |
rs4889230 | 0.87[EUR][1000 genomes] |
rs4889231 | 0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs55939311 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs56032321 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs56119129 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs56198248 | 0.90[AFR][1000 genomes];0.92[EUR][1000 genomes] |
rs56286107 | 0.91[EUR][1000 genomes] |
rs56395947 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs57606521 | 0.82[EUR][1000 genomes] |
rs58144189 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs59177227 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs59685942 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs61082942 | 0.85[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs62054594 | 0.90[ASN][1000 genomes] |
rs7185637 | 0.86[EUR][1000 genomes] |
rs7188508 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7203546 | 0.87[EUR][1000 genomes] |
rs7204040 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7206814 | 0.87[EUR][1000 genomes] |
rs73597252 | 0.89[EUR][1000 genomes] |
rs754429 | 0.81[AFR][1000 genomes];0.94[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs804889 | 0.83[ASN][1000 genomes] |
rs804895 | 0.90[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs804897 | 0.94[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs804902 | 0.87[EUR][1000 genomes] |
rs8052490 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8056972 | 0.83[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8059692 | 0.89[EUR][1000 genomes] |
rs8177851 | 0.86[EUR][1000 genomes] |
rs8177876 | 0.89[EUR][1000 genomes] |
rs8177939 | 0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs8177940 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8177942 | 0.85[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs8177943 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8177945 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8177948 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8177950 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8177959 | 0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs874437 | 0.89[EUR][1000 genomes] |
rs935942 | 0.87[EUR][1000 genomes] |
rs9806918 | 0.89[AMR][1000 genomes];0.84[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs9923732 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9925940 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9925943 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs9926174 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9929586 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs9933184 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9938965 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.86[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv948534 | chr16:80867635-81160492 | Enhancers Weak transcription Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
2 | nsv1064164 | chr16:80918138-81126967 | Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
3 | nsv542991 | chr16:80918138-81126967 | Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
4 | nsv532569 | chr16:80980356-81700149 | Weak transcription Flanking Active TSS Genic enhancers Enhancers Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
5 | nsv532597 | chr16:81009718-81388348 | Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
6 | nsv573338 | chr16:81020393-81106944 | Strong transcription Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
7 | nsv427984 | chr16:81026691-81320341 | Enhancers Genic enhancers Flanking Active TSS Weak transcription Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
8 | nsv1062724 | chr16:81052312-81137007 | Strong transcription Active TSS Flanking Active TSS Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
9 | nsv1897 | chr16:81060566-81105260 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 18 gene(s) | inside rSNPs | diseases |
10 | esv2422360 | chr16:81066033-81180727 | Flanking Active TSS Weak transcription Strong transcription Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
11 | esv2751615 | chr16:81093099-81307599 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs56166222 | ATMIN | cis | Muscle Skeletal | GTEx |
rs56166222 | GCSH///LOC730107 | Cis_1M | lymphoblastoid | RTeQTL |
rs56166222 | CENPN | Cis_1M | lymphoblastoid | RTeQTL |
rs56166222 | GCSH///LOC654085///LOC730107 | Cis_1M | lymphoblastoid | RTeQTL |
rs56166222 | GCSH | cis | Muscle Skeletal | GTEx |
rs56166222 | C16orf46 | Cis_1M | lymphoblastoid | RTeQTL |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:81079400-81109800 | Weak transcription | Brain Hippocampus Middle | brain |
2 | chr16:81080400-81110200 | Weak transcription | Ovary | ovary |
3 | chr16:81092000-81106600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr16:81093000-81109800 | Weak transcription | Brain Anterior Caudate | brain |
5 | chr16:81095000-81109400 | Weak transcription | H9 Cell Line | embryonic stem cell |
6 | chr16:81095600-81109800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
7 | chr16:81095800-81110200 | Weak transcription | Fetal Stomach | stomach |
8 | chr16:81097600-81104600 | Weak transcription | Fetal Heart | heart |
9 | chr16:81098200-81107200 | Weak transcription | Placenta | Placenta |
10 | chr16:81098800-81104800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr16:81099200-81101600 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr16:81100600-81102800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr16:81101000-81110000 | Weak transcription | Fetal Brain Male | brain |